Jove
Visualize
联系我们
这页已由机器翻译。其他页面可能仍然显示为英文。View in English
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 在pdac中,myc Ecdna促进了瘤异质性和可塑性
  1. 首页
  2. 研究领域
  3. 生物医学和临床科学
  4. 瘤学和致癌症
  5. 预测和预后标志物
  6. 在pdac中,myc Ecdna促进了瘤异质性和可塑性

相关实验视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

702

在PDAC中,MYC ecDNA促进了瘤异质性和可塑性

Elena Fiorini1, Antonia Malinova1, Daniel Schreyer2

  • 1Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy.

Nature
|March 13, 2025

在PubMed 上查看摘要

概括
此摘要是机器生成的。

超染色体DNA (ecDNA) 驱动胰腺癌中MYC基因异质性,使其能够快速适应. 然而,高的ecDNA拷贝数量给癌细胞带来了健康成本.

科学领域:

  • 癌症生物学
  • 遗传学
  • 分子瘤学

背景情况:

  • 瘤内部异质性和表型可塑性是瘤进展和治疗耐药性的关键驱动因素.
  • 癌基因剂量变化有助于细胞状态转变和表型异质性,促进体质进化.
  • 癌症的表型异质性背后的遗传机制尚不清楚.

研究的目的:

  • 研究染色体外DNA (ecDNA) 在驱动瘤基因异质性的作用.
  • 阐明ecDNA对胰腺管腺癌 (PDAC) 中MYC异质性的贡献.
  • 了解MYC剂量的变化如何影响癌细胞的适应性,形态和利基因素依赖性.

主要方法:

  • 在胰腺管腺癌 (PDAC) 样本中分析染色体外DNA (ecDNA).
  • 量化MYC瘤基因剂量变化
  • 在不同的ecDNA拷贝数下评估癌细胞适应性,形态和依赖性.

主要成果:

  • 外染色体DNA (ecDNA) 是关键瘤基因的高水平焦点放大的主要来源,包括PDAC中的MYC.
  • 不同的ecDNA水平导致MYC剂量差异,使癌细胞能够快速和可逆地适应微环境变化.
  • 在没有选择性压力的情况下,高ecDNA拷贝数对PDAC细胞造成了显著的适应性成本.

更多相关视频

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.5K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.2K

相关实验视频

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
07:08

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets

Published on: February 2, 2024

702
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
07:29

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

19.5K
Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
08:30

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry

Published on: October 9, 2018

12.2K

相关概念视频

Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
3.9K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

2.9K
The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
2.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策
  • MYC的剂量会影响癌细胞形态及其依赖性.
  • 结论:

    • 外染色体DNA (ecDNA) 是导致胰腺管腺癌 (PDAC) MYC异质性的重要遗传机制.
    • 通过ecDNA对MYC剂量进行动态调节,有助于癌细胞的适应性,但可能会带来健康成本.
    • 了解ecDNA在MYC异质性中的作用为胰腺癌进展和潜在的治疗策略提供了新的见解.